8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with cd 349 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hisa, H; Satoh, S; Takahashi, T | 1 |
Hisa, H; Satoh, S; Suzuki-Kusaba, M; Takahara, A | 1 |
2 other study(ies) available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and cd 349
Article | Year |
---|---|
Serotonin-induced vasoconstriction in dog kidney.
Topics: Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; Gallic Acid; Indoles; Ketanserin; Kidney; Male; Methysergide; Renal Artery; Renal Circulation; Serotonin; Serotonin Antagonists; Tropisetron; Vasoconstriction | 1992 |
Effects of a novel Ca2+ entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; Gallic Acid; Heart Rate; Male; Renal Circulation; Vasoconstriction; Vasopressins | 1990 |